Skip to main content
Erschienen in: Clinical Research in Cardiology 3/2019

24.08.2018 | Original Paper

Clinical and economical impact of the presence of an extended heart team throughout the balloon-expandable transcatheter aortic valve implantation procedure

verfasst von: Michal Droppa, Oliver Borst, Thomas Katzenberger, Roland Krause, Karin Bramlage, Peter Bramlage, Henning F. Lausberg, Christian Schlensak, Christian Grasshoff, Meinrad Gawaz, Tobias Geisler

Erschienen in: Clinical Research in Cardiology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Transcatheter aortic valve implantation (TAVI) is a standard therapy for aortic valve stenosis in patients at intermediate-to-high surgical risk. Previously, TAVI at our site was performed by a minimalist heart team (MHT), comprised of two interventional cardiologists, echocardiography staff and two cardiac catheterization laboratory nurses. After revision of German Federal Joint Committee (G-BA) guidelines in September 2015, the presence of an extended heart team (EHT; including a full cardiac surgical team) became mandatory throughout the TAVI procedure. We aimed to evaluate the impact of the EHT on clinical and economical outcomes.

Methods

Data was retrospectively extracted from the medical records of patients receiving an Edwards SAPIEN 3 valve at the University Hospital Tübingen, Germany, between 2014 and 2017 and matched with cost data from the national invoice system of hospitals (InEK). For comparison, patients were grouped according to whether they underwent TAVI with or without the EHT.

Results

Overall, data for 341 patients (MHT 233; EHT 118) were analysed. Baseline characteristics were largely similar between groups (mean age 81.0 years; 54.5% female), though EHT patients had a lower mean logEuroSCORE (17.5% vs. 19.8%; p = 0.011) and more prior PCI/stenting (39.0% vs. 26.9%; p = 0.022). The rate of immediate procedural death (1.7%) was comparable between groups, as was mortality at 30 days (4.2%). Overall, 1.2% of patients required conversion to surgery. The cost of the index hospitalisation (minus the prosthesis) was higher in the EHT condition (difference + €1604), largely driven by expenditure on physicians (difference + €581; p < 0.001), medical technicians (difference + €372; p < 0.001) and medical supplies (difference +€244; p = 0.001).

Conclusion

At our site, the presence of an EHT throughout the TAVI procedure appears to substantially increase hospital expenditure without significantly improving patient outcomes. We suggest that TAVI by a minimalist HT with a surgical team on call in case of emergency may be sufficient.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef
2.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ et al (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 70:252–289 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ et al (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 70:252–289
3.
Zurück zum Zitat Mollmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck KH, Hamm C (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105:553–559CrossRefPubMed Mollmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck KH, Hamm C (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105:553–559CrossRefPubMed
4.
Zurück zum Zitat Eggebrecht H, Bestehorn M, Haude M, Schmermund A, Bestehorn K, Voigtländer T, Kuck K-H, Mehta RH (2016) Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J 37:2240–2248CrossRefPubMed Eggebrecht H, Bestehorn M, Haude M, Schmermund A, Bestehorn K, Voigtländer T, Kuck K-H, Mehta RH (2016) Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J 37:2240–2248CrossRefPubMed
5.
Zurück zum Zitat Kim WK, Hamm CW (2018) Transcatheter aortic valve implantation in Germany. Clin Res Cardiol 107:81–87CrossRefPubMed Kim WK, Hamm CW (2018) Transcatheter aortic valve implantation in Germany. Clin Res Cardiol 107:81–87CrossRefPubMed
6.
Zurück zum Zitat Kiefer P, Seeburger J, Noack T, Schroter T, Linke A, Schuler G, Haensig M, Vollroth M et al (2015) The role of the heart team in complicated transcatheter aortic valve implantation: a 7-year single-centre experience. Eur J Cardiothorac Surg 47:1090–1096CrossRefPubMed Kiefer P, Seeburger J, Noack T, Schroter T, Linke A, Schuler G, Haensig M, Vollroth M et al (2015) The role of the heart team in complicated transcatheter aortic valve implantation: a 7-year single-centre experience. Eur J Cardiothorac Surg 47:1090–1096CrossRefPubMed
7.
Zurück zum Zitat Seiffert M, Conradi L, Baldus S, Schirmer J, Blankenberg S, Reichenspurner H, Diemert P, Treede H (2013) Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach. Eur J Cardiothorac Surg 44:478–484; discussion 484CrossRefPubMed Seiffert M, Conradi L, Baldus S, Schirmer J, Blankenberg S, Reichenspurner H, Diemert P, Treede H (2013) Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach. Eur J Cardiothorac Surg 44:478–484; discussion 484CrossRefPubMed
8.
Zurück zum Zitat Seidler T, Hunlich M, Puls M, Hasenfuss G, Jacobshagen C (2017) Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation. Clin Res Cardiol 106:183–191CrossRefPubMed Seidler T, Hunlich M, Puls M, Hasenfuss G, Jacobshagen C (2017) Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation. Clin Res Cardiol 106:183–191CrossRefPubMed
9.
Zurück zum Zitat Motloch LJ, Rottlaender D, Reda S, Larbig R, Bruns M, Muller-Ehmsen J, Strauch J, Madershahian N et al (2012) Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol 101:45–53CrossRefPubMed Motloch LJ, Rottlaender D, Reda S, Larbig R, Bruns M, Muller-Ehmsen J, Strauch J, Madershahian N et al (2012) Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol 101:45–53CrossRefPubMed
10.
Zurück zum Zitat Bundesministerium für Gesundheit (2015) Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Richtlinie zu minimalinvasiven Herzklappeninterventionen: Erstfassung (Notice of a decision of the Federal Joint Committee on a directive on minimally invasive heart valve interventions: initial version). Bundesministerium für Gesundheit (German Federal Ministry of Health), Berlin Bundesministerium für Gesundheit (2015) Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Richtlinie zu minimalinvasiven Herzklappeninterventionen: Erstfassung (Notice of a decision of the Federal Joint Committee on a directive on minimally invasive heart valve interventions: initial version). Bundesministerium für Gesundheit (German Federal Ministry of Health), Berlin
11.
Zurück zum Zitat Gemeinsamer Bundesausschuss (2015) Tragende Gründe zum Beschluss des Gemeinsamen Bundesausschusses über eine Richtlinie zu minimalinvasiven Herzklappeninterventionen: Erstfassung (Supporting motives for the decision of the Common Federal Committee about a directive on minimally invasive Valvular interventions: first version). Gemeinsamer Bundesausschuss, Berlin Gemeinsamer Bundesausschuss (2015) Tragende Gründe zum Beschluss des Gemeinsamen Bundesausschusses über eine Richtlinie zu minimalinvasiven Herzklappeninterventionen: Erstfassung (Supporting motives for the decision of the Common Federal Committee about a directive on minimally invasive Valvular interventions: first version). Gemeinsamer Bundesausschuss, Berlin
12.
Zurück zum Zitat Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42:S45–S60CrossRefPubMed Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42:S45–S60CrossRefPubMed
13.
Zurück zum Zitat Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD et al (2011) Standardized bleeding definitions for cardiovascular clinical trials. A consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736–2747CrossRefPubMed Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD et al (2011) Standardized bleeding definitions for cardiovascular clinical trials. A consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736–2747CrossRefPubMed
14.
Zurück zum Zitat Deutsche Krankenhausgesellschaft (DKG), Spitzenverbände der Krankenkassen (GKV), Verband der privaten Krankenversicherung (PKV) (2016) Kalkulation von Behandlungskosten, Handbuch zur Anwendung in Krankenhäusern, Version 4.0 (Calculation of treatment costs; manual for in-hospital use, version 4.0). Deutsche Krankenhaus Verlagsgesellschaf, Düsseldorf Deutsche Krankenhausgesellschaft (DKG), Spitzenverbände der Krankenkassen (GKV), Verband der privaten Krankenversicherung (PKV) (2016) Kalkulation von Behandlungskosten, Handbuch zur Anwendung in Krankenhäusern, Version 4.0 (Calculation of treatment costs; manual for in-hospital use, version 4.0). Deutsche Krankenhaus Verlagsgesellschaf, Düsseldorf
15.
Zurück zum Zitat Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Neumann F-J, Tarantini G, Zamorano JL et al (2017) SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve. Eur Heart J 38:2717–2726CrossRefPubMedPubMedCentral Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Neumann F-J, Tarantini G, Zamorano JL et al (2017) SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve. Eur Heart J 38:2717–2726CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Nijhoff F, Abawi M, Agostoni P, Ramjankhan FZ, Doevendans PA, Stella PR (2015) Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison. Circ Cardiovasc Interv 8:e002408CrossRefPubMed Nijhoff F, Abawi M, Agostoni P, Ramjankhan FZ, Doevendans PA, Stella PR (2015) Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison. Circ Cardiovasc Interv 8:e002408CrossRefPubMed
17.
Zurück zum Zitat Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G et al (2017) SOURCE 3 registry: design and 30-day results of the european postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation 135:1123–1132CrossRefPubMed Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G et al (2017) SOURCE 3 registry: design and 30-day results of the european postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve. Circulation 135:1123–1132CrossRefPubMed
18.
Zurück zum Zitat Auffret V, Lefevre T, Van Belle E, Eltchaninoff H, Iung B, Koning R, Motreff P, Leprince P et al (2017) Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol 70:42–55CrossRefPubMed Auffret V, Lefevre T, Van Belle E, Eltchaninoff H, Iung B, Koning R, Motreff P, Leprince P et al (2017) Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol 70:42–55CrossRefPubMed
19.
Zurück zum Zitat Silaschi M, Conradi L, Seiffert M, Schnabel R, Schon G, Blankenberg S, Reichenspurner H, Diemert P et al (2015) Predicting risk in transcatheter aortic valve implantation: comparative analysis of EuroSCORE II and established risk stratification tools. Thorac Cardiovasc Surg 63:472–478CrossRefPubMed Silaschi M, Conradi L, Seiffert M, Schnabel R, Schon G, Blankenberg S, Reichenspurner H, Diemert P et al (2015) Predicting risk in transcatheter aortic valve implantation: comparative analysis of EuroSCORE II and established risk stratification tools. Thorac Cardiovasc Surg 63:472–478CrossRefPubMed
20.
Zurück zum Zitat Anand A, Harley C, Visvanathan A, Shah ASV, Cowell J, MacLullich A, Shenkin S, Mills NL (2017) The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes 3:123–132PubMed Anand A, Harley C, Visvanathan A, Shah ASV, Cowell J, MacLullich A, Shenkin S, Mills NL (2017) The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes 3:123–132PubMed
21.
Zurück zum Zitat Kotronias RA, Kwok CS, George S, Capodanno D, Ludman PF, Townend JN, Doshi SN, Khogali SS et al (2017) Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc 6:e005960CrossRefPubMedPubMedCentral Kotronias RA, Kwok CS, George S, Capodanno D, Ludman PF, Townend JN, Doshi SN, Khogali SS et al (2017) Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc 6:e005960CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Arsalan M, Kim WK, Van Linden A, Liebetrau C, Pollock BD, Filardo G, Renker M, Mollmann H et al (2018) Predictors and outcome of conversion to cardiac surgery during transcatheter aortic valve implantation. Eur J Cardiothorac Surg 54:267–272CrossRefPubMed Arsalan M, Kim WK, Van Linden A, Liebetrau C, Pollock BD, Filardo G, Renker M, Mollmann H et al (2018) Predictors and outcome of conversion to cardiac surgery during transcatheter aortic valve implantation. Eur J Cardiothorac Surg 54:267–272CrossRefPubMed
23.
Zurück zum Zitat Rezq A, Basavarajaiah S, Latib A, Takagi K, Hasegawa T, Figini F, Cioni M, Franco A et al (2012) Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study. JACC Cardiovasc Interv 5:1264–1272CrossRefPubMed Rezq A, Basavarajaiah S, Latib A, Takagi K, Hasegawa T, Figini F, Cioni M, Franco A et al (2012) Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study. JACC Cardiovasc Interv 5:1264–1272CrossRefPubMed
24.
Zurück zum Zitat Clayton B, Morgan-Hughes G, Roobottom C (2014) Transcatheter aortic valve insertion (TAVI): a review. Br J Radiol 87:20130595CrossRefPubMed Clayton B, Morgan-Hughes G, Roobottom C (2014) Transcatheter aortic valve insertion (TAVI): a review. Br J Radiol 87:20130595CrossRefPubMed
25.
Zurück zum Zitat Fernandes P, Cleland A, Bainbridge D, Jones PM, Chu MW, Kiaii B (2015) Development of our TAVI protocol for emergency initiation of cardiopulmonary bypass. Perfusion 30:34–39CrossRefPubMed Fernandes P, Cleland A, Bainbridge D, Jones PM, Chu MW, Kiaii B (2015) Development of our TAVI protocol for emergency initiation of cardiopulmonary bypass. Perfusion 30:34–39CrossRefPubMed
26.
Zurück zum Zitat Eggebrecht H, Schmermund A, Mehta RH (2014) Reducing severe intraprocedural complications during transcatheter aortic valve implantation with an interdisciplinary heart team approach. Eur J Cardiothorac Surg 45:203–204CrossRefPubMed Eggebrecht H, Schmermund A, Mehta RH (2014) Reducing severe intraprocedural complications during transcatheter aortic valve implantation with an interdisciplinary heart team approach. Eur J Cardiothorac Surg 45:203–204CrossRefPubMed
27.
Zurück zum Zitat Beohar N, Kirtane AJ, Blackstone E, Waksman R, Holmes D Jr, Minha S, Alli O, Suri RM et al (2016) Trends in complications and outcomes of patients undergoing transfemoral transcatheter aortic valve replacement: experience from the PARTNER continued access registry. JACC Cardiovasc Interv 9:355–363CrossRefPubMed Beohar N, Kirtane AJ, Blackstone E, Waksman R, Holmes D Jr, Minha S, Alli O, Suri RM et al (2016) Trends in complications and outcomes of patients undergoing transfemoral transcatheter aortic valve replacement: experience from the PARTNER continued access registry. JACC Cardiovasc Interv 9:355–363CrossRefPubMed
28.
Zurück zum Zitat Eggebrecht H, Schmermund A, Kahlert P, Erbel R, Voigtlander T, Mehta RH (2013) Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9,251 patients from 46 studies. EuroIntervention 8:1072–1080CrossRefPubMed Eggebrecht H, Schmermund A, Kahlert P, Erbel R, Voigtlander T, Mehta RH (2013) Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9,251 patients from 46 studies. EuroIntervention 8:1072–1080CrossRefPubMed
29.
Zurück zum Zitat Drakopoulou M, Toutouzas K, Stathogiannis K, Latsios G, Synetos A, Oikonomou G, Penesopoulou V, Xanthopoulou M et al (2018) Impact of moderate/severe tricuspid regurgitation on survival of patients undergoing transcatheter aortic valve replacement. J Am College Cardiol 71:A2018CrossRef Drakopoulou M, Toutouzas K, Stathogiannis K, Latsios G, Synetos A, Oikonomou G, Penesopoulou V, Xanthopoulou M et al (2018) Impact of moderate/severe tricuspid regurgitation on survival of patients undergoing transcatheter aortic valve replacement. J Am College Cardiol 71:A2018CrossRef
30.
Zurück zum Zitat Khawaja MZ, Williams R, Hung J, Arri S, Asrress KN, Bolter K, Wilson K, Young CP et al (2014) Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis. Heart 100:1799–1803CrossRefPubMedPubMedCentral Khawaja MZ, Williams R, Hung J, Arri S, Asrress KN, Bolter K, Wilson K, Young CP et al (2014) Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis. Heart 100:1799–1803CrossRefPubMedPubMedCentral
Metadaten
Titel
Clinical and economical impact of the presence of an extended heart team throughout the balloon-expandable transcatheter aortic valve implantation procedure
verfasst von
Michal Droppa
Oliver Borst
Thomas Katzenberger
Roland Krause
Karin Bramlage
Peter Bramlage
Henning F. Lausberg
Christian Schlensak
Christian Grasshoff
Meinrad Gawaz
Tobias Geisler
Publikationsdatum
24.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 3/2019
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-018-1359-3

Weitere Artikel der Ausgabe 3/2019

Clinical Research in Cardiology 3/2019 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.